Trombocitakoncentrátumok

Trombocitakoncentrátumok, also known as platelet concentrates or platelet transfusions, are a blood product derived from donated blood. They are used to treat or prevent bleeding in individuals with low platelet counts or impaired platelet function. Platelets are small, irregular-shaped cell fragments that play a crucial role in hemostasis, the process of stopping bleeding by forming clots.

Trombocitakoncentrátumok are typically prepared by apheresis, a process where platelets are selectively separated from a donor's blood, or by centrifugation of whole blood donations. The collected platelets are then stored under specific conditions to maintain their viability and function. The decision to administer a platelet transfusion is based on a patient's clinical condition, the severity of bleeding, and their platelet count. Common indications include thrombocytopenia (low platelet count) due to various causes such as chemotherapy, bone marrow transplantation, or certain medical conditions.

The administration of trombocitakoncentrátumok is a medical procedure performed in a healthcare setting. Potential risks and side effects, though generally uncommon, can include allergic reactions, febrile non-hemolytic transfusion reactions, and transmission of infections. Careful patient monitoring is essential during and after the transfusion. The effectiveness of the transfusion is assessed by measuring the patient's platelet count post-transfusion.